If you made any changes in Pure these will be visible here soon.

Research Output 2018 2019

Filter
Article
2019

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 others, Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

Taxoids
Observational Studies
Retrospective Studies
Breast Neoplasms
Maintenance

Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

Bertelli, G., Trovato, R., Ugel, S., Bria, E., Milella, M., Bronte, V. & Pilotto, S., Jul 2019, In : Clinical Lung Cancer. 20, 4, p. e514-e516

Research output: Contribution to journalArticle

Crizotinib in MET deregulated or ROS1 rearranged pretreated non-small-cell lung cancer (METROS): a phase II, prospective, multicentre, two-arms trial

Landi, L., Chiari, R., Tiseo, M., D'Incà, F., Dazzi, C., Chella, A., Delmonte, A., Bonanno, L., Giannarelli, D., Cortinovis, D. L., De Marinis, F., Borra, G., Morabito, A., Gridelli, C., Galetta, D., Barbieri, F., Grossi, F., Capelletto, E., Minuti, G., Mazzoni, F. & 8 others, Verusio, C., Bria, E., Alì, G., Bruno, R., Proietti, A., Fontanini, G., Crinò, L. & Cappuzzo, F., Dec 15 2019, In : Clin. Cancer Res.. p. 7312-7319 8 p.

Research output: Contribution to journalArticle

Crizotinib in MET-deregulated or ROS1-rearranged pretreated non–small cell lung cancer (METROS): A phase II, prospective, multicenter, two-arms trial: Clinical Cancer Research

Landi, L., Chiari, R., Tiseo, M., D'Inca, F., Dazzi, C., Chella, A., Delmonte, A., Bonanno, L., Giannarelli, D., Cortinovis, D. L., de Marinis, F., Borra, G., Morabito, A., Gridelli, C., Galetta, D., Barbieri, F., Grossi, F., Capelletto, E., Minuti, G., Mazzoni, F. & 8 others, Verusio, C., Bria, E., Al, G., Bruno, R., Proietti, A., Fontanini, G., Crino, L. & Cappuzzo, F., 2019, In : Clin. Cancer Res.. 25, 24, p. 7312-7319 8 p.

Research output: Contribution to journalArticle

Crizotinib in MET-deregulated or ROS1-rearranged pretreated non–small cell lung cancer (METROS): A phase II, prospective, multicenter, two-arms trial

Landi, L., Chiari, R., Tiseo, M., D'Inca, F., Dazzi, C., Chella, A., Delmonte, A., Bonanno, L., Giannarelli, D., Cortinovis, D. L., de Marinis, F., Borra, G., Morabito, A., Gridelli, C., Galetta, D., Barbieri, F., Grossi, F., Capelletto, E., Minuti, G., Mazzoni, F. & 8 others, Verusio, C., Bria, E., Al, G., Bruno, R., Proietti, A., Fontanini, G., Crino, L. & Cappuzzo, F., 2019, In : Clinical Cancer Research. 25, 24, p. 7312-7319 8 p.

Research output: Contribution to journalArticle

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma

Rossi, E., Maiorano, B. A., Pagliara, M. M., Sammarco, M. G., Dosa, T., Martini, M., Rindi, G., Bria, E., Blasi, M. A., Tortora, G. & Schinzari, G., 2019, In : Frontiers in Oncology. 9, p. 232

Research output: Contribution to journalArticle

Melanoma
Skin
Mutation
Mitogen-Activated Protein Kinase Kinases
dabrafenib

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

Pizzuti, L., Krasniqi, E., Barchiesi, G., Della Giulia, M., Izzo, F., Sanguineti, G., Marchetti, P., Mazzotta, M., Giusti, R., Botticelli, A., Gamucci, T., Natoli, C., Grassadonia, A., Tinari, N., Iezzi, L., Tomao, S., Tomao, F., Tonini, G., Santini, D., Astone, A. & 30 others, Michelotti, A., De Angelis, C., Mentuccia, L., Vaccaro, A., Magnolfi, E., Gelibter, A., Magri, V., Cortesi, E., D'Onofrio, L., Cassano, A., Rossi, E., Cazzaniga, M., Moscetti, L., Omarini, C., Piacentini, F., Fabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Bria, E., La Verde, N., Garufi, C., Paris, I., Giotta, F., Lorusso, V., De Maria, R., Ciliberto, G., Sperduti, I., Barba, M. & Vici, P., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

Open Access
Immunohistochemistry
Breast Neoplasms
Neoplasms
Estrogen Receptors
Disease-Free Survival

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial

Capelletto, E., Migliorino, M. R., Morabito, A., Chiari, R., Grossi, F., Tiseo, M., Costanzo, F. D., Delmonte, A., Romano, G., Galetta, D., Scotti, V., Gregorc, V., Pisconti, S., Ceresoli, G. L., Conte, A. D., Ciuffreda, L., Colantonio, I., Bria, E., Ricciardi, S., Manzo, A. & 7 others, Metro, G., Morelli, A. M., Critelli, R., Pacchiana, M. V., Stura, I., Migliaretti, G. & Novello, S., 2019, In : Lung Cancer. 134, p. 210-217 8 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Appointments and Schedules
Quality of Life
Recurrence

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial

Capelletto, E., Migliorino, M. R., Morabito, A., Chiari, R., Grossi, F., Tiseo, M., Costanzo, F. D., Delmonte, A., Romano, G., Galetta, D., Scotti, V., Gregorc, V., Pisconti, S., Ceresoli, G. L., Del Conte, A., Ciuffreda, L., Colantonio, I., Bria, E., Ricciardi, S., Manzo, A. & 7 others, Metro, G., Morelli, A. M., Critelli, R., Pacchiana, M. V., Stura, I., Migliaretti, G. & Novello, S., Aug 2019, In : Lung Cancer. 134, p. 210-217 8 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Appointments and Schedules
Quality of Life
Recurrence

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial

Capelletto, E., Migliorino, M. R., Morabito, A., Chiari, R., Grossi, F., Tiseo, M., Costanzo, F. D., Delmonte, A., Romano, G., Galetta, D., Scotti, V., Gregorc, V., Pisconti, S., Ceresoli, G. L., Del Conte, A., Ciuffreda, L., Colantonio, I., Bria, E., Ricciardi, S., Manzo, A. & 7 others, Metro, G., Morelli, A. M., Critelli, R., Pacchiana, M. V., Stura, I., Migliaretti, G. & Novello, S., Aug 2019, In : Lung Cancer. 134, p. 210-217 8 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Appointments and Schedules
Quality of Life
Recurrence

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial

Capelletto, E., Migliorino, M. R., Morabito, A., Chiari, R., Grossi, F., Tiseo, M., Costanzo, F. D., Delmonte, A., Romano, G., Galetta, D., Scotti, V., Gregorc, V., Pisconti, S., Ceresoli, G. L., Conte, A. D., Ciuffreda, L., Colantonio, I., Bria, E., Ricciardi, S., Manzo, A. & 7 others, Metro, G., Morelli, A. M., Critelli, R., Pacchiana, M. V., Stura, I., Migliaretti, G. & Novello, S., 2019, In : Lung Cancer. 134, p. 210-217 8 p.

Research output: Contribution to journalArticle

Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations

Simbolo, M., Barbi, S., Fassan, M., Mafficini, A., Ali, G., Vicentini, C., Sperandio, N., Corbo, V., Rusev, B., Mastracci, L., Grillo, F., Pilotto, S., Pelosi, G., Pelliccioni, S., Lawlor, R. T., Tortora, G., Fontanini, G., Volante, M., Scarpa, A. & Bria, E., Sep 1 2019, In : Journal of Thoracic Oncology. 14, 9, p. 1651-1661 11 p.

Research output: Contribution to journalArticle

Open Access
Neuroendocrine Carcinoma
Large Cell Carcinoma
Carcinoid Tumor
Gene Expression Profiling
Lung
Estrogen Receptors
Multicenter Studies
Breast Neoplasms
Recurrence
Growth

Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: A multicentre analysis

Chiappetta, M., Leuzzi, G., Sperduti, I., Bria, E., Mucilli, F., Lococo, F., Spaggiari, L., Ratto, G. B., Filosso, P. L. & Facciolo, F., Mar 1 2019, In : European Journal of Cardio-thoracic Surgery. 55, 3, p. 405-412 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Disease-Free Survival
Lymph Nodes
Survival
Survival Rate

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer), Aug 2019, In : Lung Cancer. 134, p. 121-126 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Maintenance
Disease-Free Survival
Observation
Survival

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

On behalf of the Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer), Aug 1 2019, In : Lung Cancer. 134, p. 121-126 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Maintenance
Disease-Free Survival
Observation
Survival

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

On behalf of the Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer), Santo, A., Pilotto, S., Galetta, D., Grossi, F., Fasola, G., Romano, G., Bonanno, L., Bearz, A., Papi, M., Roca, E., Catino, A., Follador, A., Rijavec, E., Genova, C., Petrillo, P., Favaretto, A., Giannone, L., Milella, M., Tortora, G. & 2 others, Giannarelli, D. & Bria, E., 2019, In : Lung Cancer. 134, p. 121-126 6 p.

Research output: Contribution to journalArticle

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

Santo, A., Pilotto, S., Galetta, D., Grossi, F., Fasola, G., Romano, G., Bonanno, L., Bearz, A., Papi, M., Roca, E., Catino, A., Follador, A., Rijavec, E., Genova, C., Petrillo, P., Favaretto, A., Giannone, L., Milella, M., Tortora, G., Giannarelli, D. & 2 others, Bria, E. & Cancer), I. A. FONICAP. O. N. I. F. A. L., Aug 2019, In : Lung Cancer. 134, p. 121-126 6 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Maintenance
Disease-Free Survival
Observation
Random Allocation

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach

Bruni, A., Giaj-Levra, N., Ciammella, P., Maragna, V., Ferrari, K., Bonti, V., Grossi, F., Greco, S., Greco, C., Borghetti, P., Franceschini, D., Capelletto, E., Perna, M., Banna, G., Vagge, S., Baldini, E., Bria, E., Botti, A., Tiseo, M., Paci, M. & 6 others, Taraborrelli, M., Poletti, V., Granone, P., Ricardi, U., Novello, S. & Scotti, V., Jan 1 2019, In : PLoS One. 14, 11, e0224027.

Research output: Contribution to journalArticle

Open Access
lung neoplasms
Non-Small Cell Lung Carcinoma
Cells
Chemotherapy
Radiotherapy

Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach

Bruni, A., Giaj-Levra, N., Ciammella, P., Maragna, V., Ferrari, K., Bonti, V., Grossi, F., Greco, S., Greco, C., Borghetti, P., Franceschini, D., Capelletto, E., Perna, M., Banna, G., Vagge, S., Baldini, E., Bria, E., Botti, A., Tiseo, M., Paci, M. & 6 others, Taraborrelli, M., Poletti, V., Granone, P., Ricardi, U., Novello, S. & Scotti, V., 2019, In : PLoS One. 14, 11, e0224027.

Research output: Contribution to journalArticle

Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis

Rinninella, E., Cintoni, M., Raoul, P., Pozzo, C., Strippoli, A., Bria, E., Tortora, G., Gasbarrini, A. & Mele, M. C., Nov 1 2019, In : Clinical Nutrition.

Research output: Contribution to journalArticle

Stomach Neoplasms
Meta-Analysis
Biomarkers
Muscles
Confidence Intervals

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes

Cortellini, A., Leonetti, A., Catino, A., Pizzutillo, P., Ricciuti, B., De Giglio, A., Chiari, R., Bordi, P., Santini, D., Giusti, R., De Tursi, M., Brocco, D., Zoratto, F., Rastelli, F., Citarella, F., Russano, M., Filetti, M., Marchetti, P., Berardi, R., Torniai, M. & 17 others, Cortinovis, D., Sala, E., Maggioni, C., Follador, A., Macerelli, M., Nigro, O., Tuzi, A., Iacono, D., Migliorino, M. R., Banna, G., Porzio, G., Cannita, K., Ferrara, M. G., Bria, E., Galetta, D., Ficorella, C. & Tiseo, M., Aug 7 2019, In : Clinical and Translational Oncology.

Research output: Contribution to journalArticle

Multicenter Studies
Disease Progression
Therapeutics
osimertinib
Disease-Free Survival

PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer

Iacovelli, R., Ciccarese, C., Brunelli, M., Bogina, G., Munari, E., Bimbatti, D., Mosillo, C., Fantinel, E., Bria, E., Martignoni, G. & Tortora, G., Sep 2019, In : Journal of Immunotherapy. 42, 7, p. 269-273 5 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Ligands
Neoplasms
Neoplasm Metastasis

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Rossi, E., Pagliara, M. M., Orteschi, D., Dosa, T., Sammarco, M. G., Caputo, C. G., Petrone, G., Rindi, G., Zollino, M., Blasi, M. A., Cassano, A., Bria, E., Tortora, G. & Schinzari, G., Jul 2019, In : Cancer Immunology and Immunotherapy. 68, 7, p. 1179-1185 7 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Survival
Therapeutics
Uveal melanoma
pembrolizumab
Lung Neoplasms
Electrodes
Lung
Neoplasms
Tomography

Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?

Orlandi, A., Aroldi, F., Garutti, M., Di Dio, C., Garufi, G., Iattoni, E., Palazzo, A., Indellicati, G., Franceschini, G., Cassano, A., Bria, E. & Tortora, G., Dec 31 2019, In : Breast Journal.

Research output: Contribution to journalArticle

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

Gobbini, E., Chiari, R., Pizzutillo, P., Bordi, P., Ghilardi, L., Pilotto, S., Osman, G., Cappuzzo, F., Cecere, F., Riccardi, F., Scotti, V., Martelli, O., Borra, G., Maiello, E., Rossi, A., Graziano, P., Gregorc, V., Casartelli, C., Sergi, C., Del Conte, A. & 11 others, Delmonte, A., Bareggi, C., Cortinovis, D., Rizzo, P., Tabbò, F., Rossi, G., Bria, E., Galetta, D., Tiseo, M., Di Maio, M. & Novello, S., Jan 1 2019, (Accepted/In press) In : Clinical and Translational Oncology.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Retrospective Studies
Therapeutics
crizotinib
anaplastic lymphoma kinase

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

Gobbini, E., Chiari, R., Pizzutillo, P., Bordi, P., Ghilardi, L., Pilotto, S., Osman, G., Cappuzzo, F., Cecere, F., Riccardi, F., Scotti, V., Martelli, O., Borra, G., Maiello, E., Rossi, A., Graziano, P., Gregorc, V., Casartelli, C., Sergi, C., Del Conte, A. & 11 others, Delmonte, A., Bareggi, C., Cortinovis, D., Rizzo, P., Tabbò, F., Rossi, G., Bria, E., Galetta, D., Tiseo, M., Di Maio, M. & Novello, S., Oct 19 2019, In : Clinical and Translational Oncology. p. 10.1007/s12094-019-02222-8 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Retrospective Studies
Therapeutics
crizotinib
anaplastic lymphoma kinase

Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysis

Ciccarese, C., Iacovelli, R., Bria, E., Mosillo, C., Bimbatti, D., Fantinel, E., Bisogno, I., Brunelli, M. & Tortora, G., Feb 2019, In : Seminars in Oncology. 46, 1, p. 65-72 8 p.

Research output: Contribution to journalArticle

Immunotherapy
Meta-Analysis
Carcinoma
Drug Therapy
Survival
Cyclin-Dependent Kinase 4
Cyclin D
Aromatase Inhibitors
Breast Neoplasms
Disease-Free Survival
Open Access
Cyclin-Dependent Kinase 4
Cyclin D
Aromatase Inhibitors
Breast Neoplasms
Disease-Free Survival
Castration
Observational Studies
Prostatic Neoplasms
Survival
Hormones
2018

Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?

Pilotto, S., Carbognin, L., Rossi, A., Tortora, G. & Bria, E., Jun 1 2018, In : Seminars in Oncology. 45, 3, p. 176-180 5 p.

Research output: Contribution to journalArticle

Drug Therapy
Non-Small Cell Lung Carcinoma
Survival
Combination Drug Therapy
Immunotherapy

Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer

Iacovelli, R., Ciccarese, C., Mosillo, C., Bimbatti, D., Fantinel, E., Stefani, L., Simbolo, M., Romano, M., Mazzarotto, R., Brunelli, M., Bria, E., Scarpa, A., Lawlor, R. T., Artibani, W. & Tortora, G., Oct 1 2018, In : Targeted Oncology. 13, 5, p. 649-655 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Hormones
docetaxel
Proportional Hazards Models
Population

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma

Simbolo, M., Vicentini, C., Ruzzenente, A., Brunelli, M., Conci, S., Fassan, M., Mafficini, A., Rusev, B., Corbo, V., Capelli, P., Bria, E., Pedron, S., Turri, G., Lawlor, R. T., Tortora, G., Bassi, C., Guglielmi, A. & Scarpa, A., Dec 1 2018, In : Scientific Reports. 8, 1, 7119.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Biomarkers
Recurrence
Gene Amplification
p53 Genes

Hyperprogressive Disease in Patients with Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors or with Single-Agent Chemotherapy

Ferrara, R., Mezquita, L., Texier, M., Lahmar, J., Audigier-Valette, C., Tessonnier, L., Mazieres, J., Zalcman, G., Brosseau, S., Le Moulec, S., Leroy, L., Duchemann, B., Lefebvre, C., Veillon, R., Westeel, V., Koscielny, S., Champiat, S., Ferté, C., Planchard, D., Remon, J. & 8 others, Boucher, M. E., Gazzah, A., Adam, J., Bria, E., Tortora, G., Soria, J. C., Besse, B. & Caramella, C., Jan 1 2018, (Accepted/In press) In : JAMA oncology. p. E1-E10

Research output: Contribution to journalArticle

CD274 Antigen
Non-Small Cell Lung Carcinoma
Cell Death
Drug Therapy
Survival
Non-Small Cell Lung Carcinoma
Disease-Free Survival
Lymph Nodes
Survival
Survival Rate

Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis

Chiappetta, M., Leuzzi, G., Sperduti, I., Bria, E., Mucilli, F., Lococo, F., Spaggiari, L., Ratto, G. B., Filosso, P. L. & Facciolo, F., Sep 6 2018, In : European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Lymph Nodes
Disease-Free Survival
Survival
Confidence Intervals

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

Moro, M., Caiola, E., Ganzinelli, M., Zulato, E., Rulli, E., Marabese, M., Centonze, G., Busico, A., Pastorino, U., de Braud, F. G., Vernieri, C., Simbolo, M., Bria, E., Scarpa, A., Indraccolo, S., Broggini, M., Sozzi, G. & Garassino, M. C., 2018, In : Journal of Thoracic Oncology. 13, 11, p. 1692-1704 13 p.

Research output: Contribution to journalArticle

Metformin
Cisplatin
Phosphotransferases
Apoptosis
Liver
Metformin
Cisplatin
Phosphotransferases
Apoptosis
Liver

Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm

Pelosi, G., Bianchi, F., Dama, E., Simbolo, M., Mafficini, A., Sonzogni, A., Pilotto, S., Harari, S., Papotti, M., Volante, M., Fontanini, G., Mastracci, L., Albini, A., Bria, E., Calabrese, F. & Scarpa, A., 2018, In : Virchows Archiv. 472, 4, p. 567-577 11 p.

Research output: Contribution to journalArticle

Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies

di Noia, V., D'Argento, E., Pilotto, S., Grizzi, G., Caccese, M., Iacovelli, R., Tortora, G. & Bria, E., Sep 2 2018, In : Expert Opinion on Biological Therapy. 18, 9, p. 937-945 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cells
Chemotherapy
Epidermal Growth Factor Receptor
Therapeutics

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., Jan 2018, In : Clinical Lung Cancer. 19, 1, p. 93-104 12 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Mutation
Disease-Free Survival

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., Jan 2018, In : Clinical Lung Cancer. 19, 1, p. 93-104 12 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Mutation
Disease-Free Survival

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., 2018, In : Clinical Lung Cancer. 19, 1, p. 93-104 12 p.

Research output: Contribution to journalArticle

Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment

Pilotto, S., Sperduti, I., Leuzzi, G., Chiappetta, M., Mucilli, F., Ratto, G. B., Lococo, F., Filosso, P. L., Spaggiari, L., Novello, S., Milella, M., Santo, A., Scarpa, A., Infante, M., Tortora, G., Facciolo, F. & Bria, E., 2018, In : Journal of Thoracic Oncology. 13, 4, p. 568-575 8 p.

Research output: Contribution to journalArticle